Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
USP
USP
Activities:
Regulatory
Pharmaceutical
X
LinkedIn
Trending Articles
Merck's sacituzumab tirumotecan granted Breakthrough Therapy Designation by the FDA
The antibody-drug conjugate (ADC) can be used to treat patients with advanced or metastatic non-small cell lung cancer (NSCLC)
Novavax sells protein manufacturing facility to Novo Nordisk for $200m
Novo Nordisk's purchase of Novavax's Czech recombinant protein manufacturing facility will involve a full transfer of assets — including its workforce and associated support...
Precision psychiatry in action: How IMed Consultancy helped HMNC Brain Health’s Cortibon programme
AI-driven approach promises a new class of depression treatment
IMed Consultancy helps Toby Orthopaedics navigate UK regulations
Regulatory consultancy ensures compliance and confidence for Miami-based company
ACG launches ADAPT X at CPhI & PMEC India 2024
Innovative tablet feeder sets new benchmarks for efficiency and versatility in pharmaceutical packaging solutions
Upcoming event
CPhI Middle East
10–12 December 2024 | Conference | Riyadh, Saudi Arabia
See all
Related Content
Ingredients
ATCC and USP launch product range to reduce risk in vaccine development
ATCC and USP have launched the first set of products from their collaboration to advance quality and reduce risk in the development of biological therapeutics and vaccines
Regulatory
USP launches programme to speed COVID-19 treatments
US Pharmacopeia has launched the Trust Accelerated programme to expand access to free USP technical expertise and resources to support regulatory predictability
Regulatory
USP publishes new and revised sterile compounding standards
Standards help ensure quality compounded preparations to safeguard the well-being of patients and those handling the compounds
Subscribe now